No description available.

No description available.

No description available.

No description available.

No description available.

No description available.

EmrE from Escherichia coli is a member of the small multidrug resistance protein family that oligomerizes to export hydrophobic cationic antimicrobials by utilizing the proton motive force. We studied the helix-helix interactions of the four transmembrane (TM) segments of EmrE to determine how this protein might assemble into its oligomeric forms. Using a combination of biochemical and biophysical techniques, we assessed the oligomerization propensities of Lys-tagged EmrE TM peptides in membrane-mimetic environments. Our results established that each of the TMs of EmrE display detergent-sensitive self-association, but in particular, TM2 had the greatest dimerization capability that was not completely abolished even by scrambling the native sequence. Mutations made to TM2 in full-length EmrE also revealed that efflux-defective mutations are located on one face of the helix. These findings reveal another potential oligomerization site for EmrE - and perhaps SMRs - and may provide a target for development of novel efflux-inhibitors.

Multidrug resistance protein 1 (MRP1) is an integral membrane protein belonging to the ATP-binding cassette (ABC) superfamily that utilizes ATP binding and hydrolysis to transport various endogenous substrates and/or xenobiotics across membranes against a concentration gradient. The overall goal of my research was to examine the nucleotide and protein interactions of MRP1 using various biochemical methods. In the first study, Cu2+(Ph)3 which promotes cross-linking of two nearby Cys residues and limited proteolysis were used to study conformational changes of MRP1 at different stages of ATP binding and hydrolysis at the nucleotide binding domains (NBDs). The limited trypsin digestion patterns indicated that some Cys residues of MRP1 could be cross-linked in the nucleotide-free state and that the Cys cross-linked MRP1 was more susceptible to trypsinolysis. Furthermore, binding of ATP, AMP-PNP, and trapping of ADP by MRP1 prevented the cross-linking events from occurring, but binding of ATPγS did not. However, the ATPγS-bound MRP1, like nucleotide-free MRP1, showed enhanced sensitivity towards trypsinolysis. These studies show that the two ATP analogs, AMP-PNP and ATPγS, interact with MRP1 in different ways. In the second study, the interaction of MRP1 with other cellular proteins was examined. An in vivo chemical cross-linking approach combined with affinity purification and MS analysis was initially used to identify protein partners directly interacting with MRP1. When this approach proved unsuccessful, a second approach involving immunoaffinity purification of MRP1-containing complexes followed by MS analysis was adopted. Six potential candidate interacting protein partners of MRP1 were identified via this approach and two of them, FUS and drebrin, were further characterized by co-immunoprecipitation and colocalization experiments. FUS seems unlikely to be an important binding partner of MRP1 since confocal and subcellular fractionation studies showed it to be exclusively localized in the nucleus. On the other hand, drebrin depletion by siRNA knock-down resulted in a moderate decrease in MRP1 overall expression levels although the membrane localization of MRP1 remained unchanged. / Thesis (Master, Pathology & Molecular Medicine) -- Queen's University, 2008-12-08 17:44:52.767

A major hurdle facing in vitro protein characterization is obtaining soluble protein from targets that tend to aggregate and form insoluble inclusion bodies. Soluble protein is essential for any biophysical data collection and new methods are needed to approach this significant problem. Directed evolution can be used to discover mutations which lead to improved solubility using an appropriate screening method. Green fluorescent protein (GFP) has been shown to be an effective solubility reporter which can be used to screen for soluble protein variants. We have chosen three diverse enzymes as targets for improving protein solubility using this technique: arachidonate 5-lipoxygenase—an enzyme which converts fatty acids into leukotrienes, PhnG—an enzyme belonging to the bacterial carbon-phosphorus lyase pathway, and RebG—a glycosyltransferase. Error-prone PCR and DNA shuffling were used to generate libraries of mutants which were subsequently cloned into a GFP-fusion screening vector. From the evolution of 5LO and RebG, much was learned about the optimization of the protocols involved in this methodology, including valuable information about how to avoid common “false-positive” results in which fluorescent colonies arise while screening but do not represent an improvement of the target. Evolution of these two targets did not result in an improvement of solubility, however truncation strategies may still prove to be effective, and more work needs to be done in this area. Evolution of PhnG successfully produced one variant, named clone B6, which showed both an improvement in expression and folding over wild type PhnG. It was also discovered that GFPuv can act as an effective solubility enhancing fusion tag for PhnG. Prior to the current studies PhnG had not been effectively expressed and purified in E. coli , however purification and refolding of resolubilized inclusion bodies of the clone B6 PhnG-GFP fusion construct was shown to yield enough soluble protein for future crystallographic studies. / Thesis (Master, Chemistry) -- Queen's University, 2009-10-09 12:26:03.353

Members of the Sco protein family have been proposed to function in the assembly of cytochrome c oxidase in the respiratory chain of all aerobic life forms. The Sco protein in Bacillus subtilis, BsSco, is characterized for its folding/unfolding behavior in the presence or absence of Cu(II) in this study. The folding/unfolding of apo-BsSco is investigated by CD and fluorescence spectroscopies. BsSco follows an apparent two-state mechanism in both folding and unfolding processes. The two apo forms of BsSco, reduced and oxidized, exhibit similar equilibrium stabilities suggesting that the formation of an intramolecular disulfide in oxidized apo-BsSco does not add to BsSco’s overall stability. In contrast, Cu(II) binding to reduced apo-BsSco results in extreme stabilization and resistance to unfolding in urea. However, when Cu(II) is present with unfolded, reduced apo-BsSco, the protein is rapidly oxidized. Another widely used denaturant, GdnHCl, is able to unfold Cu(II)-BsSco by allowing the loss of Cu(II) from the metal/protein complex. When the presence of Cu(II)-BsSco complex and the protein’s folded state are monitored simultaneously, the unfolding of Cu(II)-bound BsSco occurs coincidently with Cu(II) dissociation. We suggest that the loss of Cu(II) binding and the loss of BsSco’s native conformation are coincident, which leads to the conclusion that Cu(II)-BsSco does not unfold until it forfeits Cu(II). The kinetics of folding/unfolding of reduced, oxidized and Cu(II) bound BsSco are explored by stopped-flow fluorescence spectroscopy. The rate constants at which the two apo forms of BsSco fold and unfold are measured and plotted versus denaturant concentration. Reduced and oxidized forms of apo-BsSco are similar in folding and unfolding kinetics. Cu(II)-involved refolding kinetics of BsSco show that Cu(II) is able to accelerate the rate of refolding. However, the involvement of Cu(II) in the refolding process results in two competing processes: oxidation and Cu(II) binding. Which process predominates depends on the refolding rate which further depends on the denaturant concentration. This study has provided direct evidence for metal-involved stabilization of BsSco which is beneficial to efficiently fulfill its copper trafficking duty in a cellular environment. / Thesis (Master, Biochemistry) -- Queen's University, 2010-12-17 17:24:09.598